Dogwood Therapeutics, Inc. SEC filings DWTX
Dogwood Therapeutics, Inc. has 328 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 12, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Jan 13, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 21, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 24, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Other events
|
Apr 3, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 14, 2025 | Mar 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 12, 2025 | Mar 12, 2025 |
| 8-K/A | Amended current report | Dec 18, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 21, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 30, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 7, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 20, 2024 | May 19, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Listing notice
|
May 7, 2024 | May 1, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 6, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 7, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Agreement ended
|
Sep 18, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Other events
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 17, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 14, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Other events
|
May 25, 2023 | May 24, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Other events
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2023 | Apr 13, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 28, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 2, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2022 | Sep 27, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 20, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 19, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Auditor change
|
Jun 3, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Other events
|
Dec 17, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 12, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2021 | May 14, 2021 |
| 8-K |
Current report
Officer or director change
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2021 | Mar 18, 2021 |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1818844
- Former names
- Virios Therapeutics, Inc. (until Oct 15, 2024); Virios Therapeutics, LLC (until Dec 16, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.